The US and Canada have healthcare, life science and medical device industries that are complex and interconnected.
On March 6, President Donald Trump instituted a 25 percent ad valorem rate of duty on goods imported from Canada under the International Emergency Economic Powers Act.[1] The tariffs will not be implemented on goods that comply with the United States-MexicoCanada Agreement until April 2.[2] In turn, Canada has announced a $155 billion tariff package on the US.[3]
Download the full Law360 article, "Mitigating Tariff Risks For Healthcare In US And Canada."
Publication
Even when shareholder proposals fall short at the polls, their influence can resonate beyond the vote count and plant the seed for potential shifts in shareholder engagement themes.
Publication
The Ontario Securities Commission (OSC) is seeking public comment until September 3, 2025, on a proposal (the Proposal) to prohibit persons and companies from participating in prospectus offerings and private placements made by reporting issuers in Ontario when such persons or companies recently sold short the equity security being offered.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025
